FacebookTwitterGoogle+RedditEmail

New Year’s Resolutions for the Drug Industry

by MARTHA ROSENBERG

There was only one thing worse than being unemployed in 2009: working for the drug sector.

Not only did the two biggest drug settlements in US history occur in 2009–Eli Lilly’s $1.42 billion for mismarketing Zyprexa and Pfizer’s $2.3 billion for Bextra, Geodon, Lyrica and Zyvox fraud–the Supreme Court ruled people can sue if they’re harmed by a prescription drug even if it had FDA approval.

No wonder Wyeth and Pfizer and then Merck and Schering-Plough formed defensive mergers in 2009, the former timed to knock out headlines about the Bextra settlement.

High profile suicides also occurred in 2009 prompting the FDA to add black box warnings to the asthma drugs Singulair, Accolate and  Zyflo, the antismoking drugs Chantix and Zyban and authorities to question the antidepressants given to 80 percent of Iraq war veterans with post traumatic stress disorder.

The open secret of industry subsidized journal articles and Continuing Marketing, sorry Medical Education courses (CMEs) also came under Congressional investigation in 2009–as did the drug industry ties of faux grassroots groups like the National Alliance on Mental Illness (NAMI) and high flying researchers like Harvard’s Joseph Biederman, MD.

Clearly the drug industry needs New Year’s Resolutions–and to honor them better than the Corporate Integrity Agreements with the government it keeps breaking.

1. Our reps will wait their turn in medical offices and refrain from waltzing in front of ailing patients because they think their time is more valuable. They will NOT get their own room in medical offices with laptop stations, ice water and swivel chairs or chatter about the stress of sales quotas on their cells in the waiting room. Female reps will not “sell” with cleavage and spike heels. Males reps will not high five each other or call the doctor “dude.” Reps who sold drugs that were later withdrawn will be banished.

2. In addition to admitting to the Justice Department we mismarketed Seroquel, Zyprexa, Risperdal and Geodon and looted Medicaid budgets, we will cease selling the actual drugs. We admit that even though forgiveness is cheaper than permission for us, it isn’t for the millions of children, poor and institutionalized people who develop lifelong diabetes and metabolic disorders from the drugs.

3. We will stop upgrading anxiety to depression, depression to bipolar disorder and bipolar disorder to “treatment resistant depression” to sell drugs. We will admit that studies are beginning to show that the reason depression is sometimes treatment resistant is because it wasn’t depression to begin with but consumer advertising. We will admit our cocktails of depression/bipolar/mood brightener/mood stabilizer drugs occlude the fact that none work individually, raise insurance rates and create withdrawal symptoms in patients who might have been fine before.

4. We will admit hormone therapy increases the risk of breast cancer by 26 percent, heart attacks by 29 percent, stroke by 41 percent and doubles the risk of blood clots and dementia. We will further admit it is associated with lung, ovarian, endometrial and gall bladder cancer, malignant melanoma, asthma, lupus, scleroderma, non-Hodgkin’s lymphoma, urinary incontinence and hearing loss—and the only researchers promoting it are making money off it.

5. We will stop trying to replace the hormone market with a thinning bones market through an osteoporosis scare campaign and admit that we made up the term “osteopenia” at the same time we planted bone density measuring machines in medical offices. Nor will we keep recommending seizure drugs for fibromyalgia pain women don’t know they have yet to make up for shrinking hormone and antidepressant markets.

6. We will stop replacing $600 a month blockbuster drugs insurers no longer wave through with vaccines and biologics no one wants or needs. We will give up the attempt to vaccinate boys with Gardasil when it didn’t even work with girls or ship it to poor countries plagued with HIV, malaria or dengue fever. We will stop selling biologics like Humira which cause cancer and infections like TB to perfectly health college kids with Crohn’s disease scare campaigns.

7. We will buy every child under 12 in America a bicycle or skate board as reparations for our reign of terror treating them for depression, bipolar disorder, ADD, ADHD, mixed manias, oppositional and conduct disorders, sleep and mood disorders, schizophrenia, agitation, anxiety and other “psychopathologies” they may not have even had.

8. Instead of storming Capitol Hill when the government threatens to cut off our livestock antibiotics gravy train, we promise to develop safe antibiotics for people. And speaking of safe, we will renounce the hormones, growth enhancers and pesticides we dump on factory farms which sicken the animals, environment, farm workers and food consumers.

9. We will stop insulting the public’s intelligence by claiming that everyone including  people without high cholesterol should take Crestor because we want to sell statins. We will stop implying Vytorin works just because some have forgotten we sat on studies that show it doesn’t work in a multi-year con.

10.We will stop rolling out celebrities like Sally Field and Brooke Shield to hawk drugs and acknowledge the celebrity drug spokesmen the public remembers most are Michael Jackson, Anna Nicole Smith and Brittany Murphy.

MARTHA ROSENBERG can be reached at: martharosenberg@sbcglobal.net

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

Weekend Edition
December 02, 2016
Friday - Sunday
Jeffrey St. Clair
Roaming Charges: The CIA’s Plots to Kill Castro
Paul Street
The Iron Heel at Home: Force Matters
Pam Martens - Russ Martens
Timberg’s Tale: Washington Post Reporter Spreads Blacklist of Independent Journalist Sites
Andrew Levine
Must We Now Rethink the Hillary Question? Absolutely, Not
Joshua Frank
CounterPunch as Russian Propagandists: the Washington Post’s Shallow Smear
David Rosen
The Return of HUAC?
Rob Urie
Race and Class in Trump’s America
Patrick Cockburn
Why Everything You’ve Read About Syria and Iraq Could be Wrong
Caroline Hurley
Anatomy of a Nationalist
Ayesha Khan
A Muslim Woman’s Reflections on Trump’s Misogyny
Michael Hudson – Steve Keen
Rebel Economists on the Historical Path to a Global Recovery
Russell Mokhiber
Sanders Single Payer and Death by Democrat
Roger Harris
The Triumph of Trump and the Specter of Fascism
Steve Horn
Donald Trump’s Swamp: Meet Ten Potential Energy and Climate Cabinet Picks and the Pickers
Louis Proyect
Deepening Contradictions: Identity Politics and Steelworkers
Ralph Nader
Trump and His Betraying Makeover
Stephen Kimber
The Media’s Abysmal Coverage of Castro’s Death
Dan Bacher
WSPA: The West’s Most Powerful Corporate Lobbying Group
Nile Bowie
Will Trump backpedal on the Trans-Pacific Partnership?
Ron Ridenour
Fidel’s Death Brings Forth Great and Sad Memories
Missy Comley Beattie
By Invitation Only
Fred Gardner
Sword of Damocles: Pot Partisans Fear Trump’s DOJ
Renee Parsons
Obama and Propornot
Dean Baker
Cash and Carrier: Trump and Pence Put on a Show
Jack Rasmus
Taming Trump: From Faux Left to Faux Right Populism
Ron Jacobs
Selling Racism—A Lesson From Pretoria
Julian Vigo
The Hijos of Buenos Aires:  When Identity is Political
Matthew Vernon Whalan
Obama’s Legacy
Subcomandante Insurgente Galeano
By Way of Prologue: On How We Arrived at the Watchtower and What We Saw from There
Aidan O'Brien
Fidel and Spain: A Tale of Right and Wrong
Carol Dansereau
Stop Groveling! How to Thwart Trump and Save the World
Kim Nicolini
Moonlight, The Movie
Evan Jones
Behind GE’s Takeover of Alstom Energy
James A Haught
White Evangelicals are Fading, Powerful, Baffling
Barbara Moroncini
Protests and Their Others
Christopher Brauchli
Parallel Lives: Trump and Temer
Joseph Natoli
The Winds at Their Backs
Cesar Chelala
Poverty is Not Only an Ignored Word
David Swanson
75 Years of Pearl Harbor Lies
Alex Jensen
The Great Deceleration
Nyla Ali Khan
When Faith is the Legacy of One’s Upbringing
Gilbert Mercier
Trump Win: Paradigm Shift or Status Quo?
Stephen Martin
From ‘Too Big to Fail’ to ‘Too Big to Lie’: the End Game of Corporatist Globalization.
Charles R. Larson
Review: Emma Jane Kirby’s “The Optician of Lampedusa”
David Yearsley
Haydn Seek With Hsu
FacebookTwitterGoogle+RedditEmail